Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
The European Medicines Agency (EMA) announced on Monday that it will be discontinuing its presence on X, opting instead to utilize rival platform Bluesky.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback